Navigation Links
UMass Medical School researchers receive $8.5M grant award to fight AIDS
Date:10/24/2007

WORCESTER, Mass. As the HIV/AIDS epidemic continues around the globe laying claim to more than 25 million lives and infecting over 39 million, researchers continue to search for both a cure and improved treatments for those suffering with this disease. Now the leading cause of death worldwide among 15 to 59 year olds, AIDS is a remarkably resilient adversary with the potent ability to evolve rapidly. This evolution dramatically complicates treatment, decreasing the effectiveness of existing drugs and necessitating the continual development of new therapeutics. University of Massachusetts Medical School Professor of Biochemistry & Molecular Pharmacology Celia A. Schiffer, PhD, is at the forefront of investigations to elucidate how HIV develops resistance to current drugs.

As a principal investigator of a National Institutes of Health Institute of General Medical Sciences Program Project Grant first awarded in 2001, Dr. Schiffer has comprised a stellar team of scientists from around the nation to develop HIV drugs that are less vulnerable to drug resistance. In recognition of the success of her efforts, Schiffer was recently awarded a full, five-year renewal of the project, Targeting Ensembles of Drug Resistant HIV-Protease. The renewal, totaling more than $8.5 million, will speed studies that seek a better understanding of inhibitor recognition and the development of new methodologies for designing inhibitors against HIV and other viruses and infections that have a propensity for acquiring drug resistance.

According to Terry R. Flotte, MD, executive deputy chancellor of UMMS and dean of the School of Medicine, the renewal reflects the NIHs confidence in Schiffers scientific aims. This work clearly illustrates how the advance of molecular biology can lead to direct benefit to patients. Dr. Schiffer's efforts to define exactly how HIV can become resistant to current drugs are vital to the development of better strategies to control HIV/AIDS.
'/>"/>

Contact: Kelly Bishop
kelly.bishop@umassmed.edu
508-856-2000
University of Massachusetts Medical School
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
2. Automatic extraction of gene/protein biological functions from biomedical text
3. Vital step in cellular migration described by UCSD medical researchers
4. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
5. Medical molecules designed to respond to visible light that can penetrate tissue
6. Medical whistleblowers speak out
7. UCSD medical/bioengineering reseachers show titanium debris satobtage artificial joints
8. Innovative coating could give medical implants a longer life
9. Natural tumor suppressor in body discovered by UCSD medical researchers
10. Protein synthesis can be controlled by light, opening way for new scientific, medical applications
11. Modified collagen could yield important medical applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2015)... , Aug. 19, 2015  VOXX International Corporation ... has entered into a Definitive Agreement to purchase ... iris authentication market leader EyeLock through an acquiring ... have a controlling interest in the acquiring entity. ... completion of due diligence.  Expanding on its existing ...
(Date:8/18/2015)... , Aug. 17, 2015 Research and ... of the "Global Biometric Authentication & Identification ... Estimation & Forecast, 2015-2020" report to their ... and identification systems market is expected to grow ... to 2020 and generate over $25 billion (approximately) ...
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions , ... entire spectrum of clinical research, is proud to announce ... company,s comprehensive SaaS-based eClinical technology platform, has led the ... first two quarters of 2015.   Q2 2015 and ... quarters measured by contract value sold in the company,s ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2MedNet Solutions Experiences Explosive Corporate Growth 2
... to stitch graphene and hexagonal boron nitride (h-BN) into ... for materials scientists. The technique has implications for ... below the limitations of silicon determined by Moore,s Law. ... Rice,s Benjamin M. and Mary Greenwood Anderson Professor in ...
... March 1, 2010 The underlying causes of the debilitating ... study published online in Genome Research March ... network analysis has revealed surprising new insights into how ... Researchers are actively working to identify the direct ...
... ... ... ... ...
Cached Biology News:Rice researchers make graphene hybrid 2Rice researchers make graphene hybrid 3Scientists identify age-associated defects in schizophrenia 2Oberthur Technologies Receives Product Innovation Award 2Oberthur Technologies Receives Product Innovation Award 3Oberthur Technologies Receives Product Innovation Award 4Oberthur Technologies Receives Product Innovation Award 5
(Date:8/28/2015)... VANCOUVER , Aug. 28, 2015 /PRNewswire/ - ... clinical stage regenerative medicine company focused on the ... results for the quarter ended June 30, 2015, ... statements and management report are available at ... www.replicel.com . "RepliCel expects to ...
(Date:8/27/2015)... 2015  Neogen Corporation (NASDAQ: NEOG ) announced ... United Kingdom -based Lab M Holdings, a ... diagnostic systems. Lab M was founded ... of microbial testing and diagnostic products for the global ... currently sells into more than 70 countries worldwide, and ...
(Date:8/27/2015)... 2015 HUYA Bioscience International (HUYA) today announced the ... Society of HTLV-1, held this week at the University ... the Society is to promote research on HTLV-1 and ... technology and research related to these fields to advance ... is proud to support this prestigious conference," said ...
(Date:8/27/2015)... ... August 27, 2015 , ... Proove Biosciences, ... data on the relationship of genetics and hypertension at the International Academy ... in Vancouver, British Columbia, Canada. The event, which boasts an extensive overview of ...
Breaking Biology Technology:RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5Neogen acquires U.K.-based Lab M Holdings 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3
... EATONTOWN, N.J., Dec. 11 Osteotech, Inc.,(Nasdaq: ... biologic products for,regenerative healing, announced today that its Board ... up to $5.0 million of,Osteotech,s common stock may be ... time at current market prices through open-market and privately,negotiated ...
... Netherlands, Dec. 11 Myngle,( http://www.myngle.com ), the ... winning ICT company at the Europe Unlimited,s European ... EVS is a showcase ... biotech and new energy entrepreneurs from all over ...
... Neogen Corporation,(Nasdaq: NEOG ) announced today that ... to purchase up to 500,000 shares of the company,s,common stock. ... program first approved in 1999. , ... market or in negotiated,transactions, depending on market conditions and other ...
Cached Biology Technology:Osteotech Announces Stock Repurchase Program 2Myngle Best ICT Company at the European Ventures Summit 2Neogen Announces New Share Repurchase Program 2
Peptide-affinity Purified Polyclonal Antibody to Sphingolipid Receptor Edg8/S1P5...
Peptide-affinity Purified Polyclonal Antibody to MAML1 / Mastermind Peptide with sequence VLPTCPMAEFALPR, from N Terminus of the protein sequence according to NP_055572....
DNA sequencing - plasmids or PCR fragments, 3-7 working days service....
LEAF™ Purified anti-human/mouse/rat ICOS...
Biology Products: